Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Vunakizumab in Lupus Nephritis
NCT04924296Phase 2Unknown
- Sponsor
- Suzhou Suncadia Biopharmaceutical
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of vunakizumab in lupus nephritis (LN), sponsored by Suzhou Suncadia Biopharmaceutical. Status: unknown.
02
Drugs
vunakizumab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT04924296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04924296.